From the Tropics for the Tropics

NEWSLETTER - Issue 116 - March 15, 2021

Without autonomy in biotechnology, Brazil becomes hostage for vaccine acquisition

Country does not have a technology able to supply the lack

Manaus shows that natural infection does not generate protection and cannot be an option for the world

Loss of immunity after the first wave and the most transmissible virus variant may explain the increase in cases from 552 in December to 3,431 in January

Impact factor: arbiter of excellence?

Research and researchers on tropical diseases are undervalued by bibliographic metrics due to the little economic impact they represent


Ebola deaths in Guinea put country in alert

To prevent the spread of the disease, the local Ministry of Health has officially declared an Ebola epidemic in the southeast of the country

Case report

Case report: Seven cases of cutaneous leishmaniasis in the penis

Challenges in the diagnosis of genital ulcers: a series of cases of genital leishmaniasis

Good Science

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Sputnik V COVID-19 vaccine candidate appears safe and effective

Inferring the effectiveness of government interventions against COVID-19

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of


Brazilian Society of Tropical Medicine
Center for Tropical Medicine - UnB
Monday to Friday from 8am to 12pm and from 14pm to 18pm - PO Box 4356 - Room 43C - 70904-970
Brasilia - DF - Phone/Fax: (61) 3307-1154

Carlos Henrique Nery Costa

Assignment editors:
Guilherme Werneck
Carlos Henrique Nery Costa

Denise de Quadros
MTb 8458 DRT/RS

Pedro Costa

Graphics and diagramation:
Leandro Matos